Using Biotechnology to Slow Down Alzheimer's Symptoms

It can be frustrating for people affected by Alzheimer’s when it’s been so long without any new treatments on the horizon. But one thing to take comfort in is that every time researchers identify something that doesn’t work, they’re one small step closer to finding the right combination of pharmaceuticals that do work. As biotechnology continues to advance, there’s hope that innovation for Alzheimer’s treatments will also blossom.

Sources

https://www.bio.org/what-biotechnology

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525971/

https://www.alz.org/facts/

https://www.alz.org/alzheimers_disease_standard_prescriptions.asp

http://www.businessinsider.com/axovant-david-hung-on-what-happens-if-intepirdine-fails-2017-8

https://www.scientificamerican.com/article/why-alzheimer-s-drugs-keep-failing/

https://www.forbes.com/sites/matthewherper/2017/09/26/axovant-raised-hundreds-of-millions-around-its-alzheimers-drug-it-just-failed/#5e1fa83a3f69

http://www.businessinsider.com/roivant-and-vivek-ramaswamy-raise-11-billion-from-softbank-vision-fud-2017-8

http://www.dailymail.co.uk/health/article-4802898/Eye-test-spot-Alzheimer-s-disease-early-stages.html

https://www.nytimes.com/2017/10/11/well/mind/high-blood-pressure-in-midlife-tied-to-later-dementia.html?_r=0